Dark Forest Capital Management LP Denali Therapeutics Inc. Transaction History

Dark Forest Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $15,341 - $25,005	-529 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$42.59 - $55.02 $2,810 - $3,631	-66 Reduced 11.09%	529 $24,000
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $28,700 - $46,312	592 Added 19733.33%	595 $30,000
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $150 - $235	3 New	3 $0

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.